Home / Pharmaceutical / Electronic Health Records - Charting the Future of Health Care

Electronic Health Records - Charting the Future of Health Care

Published: Mar 2015 | No Of Pages: 53 | Published By: CBR Pharma Insights

Electronic Health Records have been in limited use since the 1960s, but their adoption received a major boost when they became more of a focus for the US government. In 2004, President Bush put forth the goal of having every American covered by an EHR within 10 years. In 2009, President Obama added the key element of funding under the American Recovery and Reinvestment Act. The EHR Meaningful Use Incentive programs funded under the ARA were further bolstered by programs in the 2010 health care reform legislation which promoted Accountable Care Organizations.

After the results of the November elections and the Supreme Courts ruling upholding the individual mandate, the future for health care reform would look more sure. However, recently some Republican members of congress have turned their attention to EHR programs, questioning whether they are an effective use of funding.

The report, Electronic Health Records - Charting the Future of Health Care, was designed to provide insights and analysis on a topic that is being felt from government agencies to treating physicians, while also impacting the pharmaceutical industry. CBR Pharma Insights not only provides in-depth analysis on the technology being used, the adoption of this technology, and the trends being seen locally and globally, but also how EHRs could impact pharmaceutical companies.

Scope

  • Development of Electronic Health Records
  • 2010 Health Care reform programs for EHRs
  • Technology
  • Adoption of EHRs
  • Impact of EHR use
  • EHR use outside of the US
  • The outlook for EHRs

Key Reasons to Purchase

  • Understand and evaluate the criticisms behind the use of Electronic Health Records
  • Analyze the challenges facing Electronic Health Records adoption
  • Understand the role government has played in the development of Electronic Health Records in the US and the debates that are currently taking place over their use
  • Gain insights around the attempts being made to develop Electronic Health Records systems throughout the world, where they are showing positive signs of success, and where more work needs to be done
  • Assess the potential benefits of the use of Electronic Health Records for the pharmaceutical industry and the opportunities that exist for your company

Executive Summary
Chapter 1: Development of Electronic Health Records
Definition
Early use
Pre-reform programs
2010 Health Care reform programs for EHRs
Meaningful Use incentive programs
Post-election direction for EHRs

Chapter 2: Technology
EHR systems
Mobile technology
HIPAA and privacy

Chapter 3: Adoption of EHRs
Adoption rates
Physician opinions
Impact on the physician-patient relationship
Implementation challenges

Chapter 4: Impact of EHR use
Case study: Diabetes
Case study: Diagnostic imaging
Case study: preventative care
Case study: drug safety

Chapter 5: EHR use outside of the US
Canada
Europe
Asia
Emerging markets
Lessons of implementation

Chapter 6: The outlook for EHRs
Politics
Billing
Cloning
The CBR View
Appendix

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +